Clinical Trial Update: Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study to assess how omeprazole and ritonavir influence the pharmacokinetics of GSK2336805 in healthy adults; the study was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GSK2336805
• Omeprazole (Omeprazole)
• Ritonavir (Ritonavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED